HCG, human chorionic gonadotropin, is a hormone that imitates luteinizing hormone. In men it tells the testes to produce testosterone, which is why it appears in two very different conversations: fertility treatment, and keeping testicular function alive during a course of androgens.
It is also sold with claims it cannot support, including fat loss. This guide separates the label, the trial evidence and the marketing.
Key facts about HCG
| What it is | Glycoprotein hormone, acts as a luteinizing hormone analogue |
| Labelled male use | Selected cases of hypogonadotropic hypogonadism |
| Labelled male dose | 500 to 1000 USP units three times a week for 3 weeks, then reassessed |
| Effect on fat | None established. The label states HCG has no known effect on fat mobilization or appetite |
| Common off label use | During a cycle to preserve testicular function, and before recovery |
| Main monitoring | Total testosterone, estradiol, hematocrit, semen analysis if fertility is the goal |
The third tile is there on purpose. HCG diets are still sold, and the label contradicts them in plain language.
What HCG is
Human chorionic gonadotropin is a hormone produced in pregnancy and used as a medicine. Structurally it resembles luteinizing hormone closely enough to activate the same receptor in the testes. That single fact explains everything it does in a man: it stimulates the Leydig cells to produce testosterone, and it does so whether or not the pituitary is sending its own signal.
How it acts in men
That is the entire rationale for using it on cycle. It substitutes for a signal, it does not repair the axis.
What the label covers
The approved male indication is narrow: selected cases of hypogonadotropic hypogonadism, meaning hypogonadism caused by pituitary deficiency. The labelled schedule is 500 to 1000 USP units three times a week for three weeks, followed by the same dose after a break if the response warrants it.
| Statement in the label | What it means |
|---|---|
| Indicated for selected cases of hypogonadotropic hypogonadism in males | It is a treatment for a pituitary cause, not for general low testosterone |
| 500 to 1000 USP units three times weekly for 3 weeks | The only male dosing written into the label |
| No known effect on fat mobilization, appetite or fat distribution | The fat loss claims have no basis in the product information |
| Not shown to be effective as an adjunct in obesity | Explicitly stated, in capitals, in the label |
HCG on cycle
During a course of androgens, luteinizing hormone falls to near zero, the testes stop producing testosterone, and volume decreases. HCG given during that period keeps the testes responsive, so recovery after the cycle starts from a better place.
What this does and does not achieve:
- it maintains testicular volume and responsiveness while the axis is suppressed
- it raises intratesticular and serum testosterone, which can also raise estradiol
- it does not prevent suppression of the pituitary, so it is not a substitute for recovery afterwards
- it does not replace the need to check blood work
HCG and post cycle therapy
There are two schools and the difference matters. One uses HCG in the gap between the last injection and the start of a SERM, on the reasoning that it restarts testicular function before the pituitary is asked to take over. The other skips it entirely and relies on a SERM alone.
A 2026 review of post cycle therapy describes the evidence honestly: SERMs, HCG and aromatase inhibitors are all used, some studies suggest faster short term hormonal and seminal recovery, spontaneous recovery happens in most people within months anyway, and the evidence base is weak. If you want the fuller picture of that phase, our guide to post cycle therapy covers it.
Fertility and TRT
Testosterone therapy suppresses sperm production, and this is where HCG earns its place in modern practice. A 2026 review on TRT induced reproductive suppression describes the mechanism plainly: prolonged testosterone use reduces gonadotropin output, lowers intratesticular testosterone, impairs spermatogenesis and shrinks the testes. It lists hCG, FSH and SERMs as strategies that can support recovery in some patients, while noting that effectiveness varies.
A second 2026 review of gonadotropins in male infertility places hCG among the principal tools across hypogonadotropic hypogonadism, iatrogenic suppression and other causes, and notes that the strength of evidence differs considerably between those indications. In plain terms: strongest in pituitary causes, weaker in other scenarios.
Doses used in practice
Outside the label, common practice uses smaller and more frequent doses than the labelled course, on the reasoning that steady receptor stimulation produces less estradiol spike than large intermittent injections. The vials and the rest of the recovery range are in cycle support.
| Context | Pattern described in practice | Reality check |
|---|---|---|
| Labelled hypogonadotropic hypogonadism | 500 to 1000 USP units three times weekly, three weeks | The only approved male schedule |
| On cycle, maintenance | 250 to 500 units two or three times weekly | Not studied as a performance protocol |
| Before recovery | Short course, then a SERM | Timing is the contested part |
| Fertility planning | Prescribed and monitored by a specialist | Requires semen analysis, not guesswork |
Side effects and monitoring
| Effect | Why it happens | What to check |
|---|---|---|
| Estradiol rise | HCG stimulates testosterone production, which aromatizes | Sensitive estradiol, nipple sensitivity, water retention |
| Hematocrit rise | More testosterone means more red cell production | Complete blood count |
| Testicular discomfort | Rapid stimulation after a period of shutdown | Report if persistent |
| Mood and libido swings | Hormone fluctuation, especially with large intermittent doses | Log symptoms against dose timing |
| Fertility changes | Stimulation is not the same as normal spermatogenesis | Semen analysis, not assumptions |
Timing: the part people get wrong
HCG is not a drug you take whenever the box arrives. Its usefulness depends on when in the cycle it is used and how it is stopped.
| When | What it does | Common mistake |
|---|---|---|
| From the first weeks of a cycle | Keeps the testes responsive before they atrophy | Waiting until the end, when the tissue has been shut down for weeks |
| Near the end of a cycle | Partially restores testicular function | Running it right up to the start of a SERM without a gap |
| After the cycle | Not the main tool; the axis needs its own recovery | Using HCG as if it replaced post cycle therapy |
| With testosterone therapy | Preserves fertility in men who want children | Assuming fertility is preserved without a semen analysis |
The pattern is consistent: HCG works best as maintenance while the axis is suppressed, and worst as an emergency measure at the end. That is also why the labelled course is short and reassessed rather than run indefinitely.
What to check before you buy
HCG is a protein hormone, which makes handling more important than for a tablet. Two practical points follow.
- Cold chain. Reconstituted HCG degrades and is normally stored refrigerated, so a product that arrived warm has been through something.
- Batch and expiry. The batch code is what ties a vial to a production run, and expiry dates on unapproved products are worth checking against what the supplier claims.
None of this replaces a prescription, but these are the checks that tell you whether what arrived is what was ordered.
Frequently Asked Questions
Where this fits on this site
HCG belongs with the recovery tools: post cycle therapy, Clomid for men and Arimidex for estrogen control. For the therapy side of the same question, see the guide to TRT.
- DailyMed label, Pregnyl (choriogonadotropin alfa): male indication, 500 to 1000 USP units three times weekly, and the statement that HCG has no effect on fat mobilization or appetite
- Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression, 2026. PMID 42666625
- The therapeutic role of gonadotropins in male factor infertility, 2026. PMID 42997202
- Post-cycle therapy after androgen abuse: a narrative review, Endocrine Connections, 2026. PMID 42644333
Medical disclaimer. This article is informational and does not replace advice from a licensed physician. HCG is a prescription medicine, and its use for fertility or recovery requires monitoring that a forum cannot provide.